FIRST-TO-SECOND PROGRESSION-FREE SURVIVAL RATIO AS A PREDICTOR FOR OVERALL SURVIVAL IN OVARIAN CANCER

被引：0
|
作者：
Salman, L. [1 ]
Gandelsman, E. [1 ]
Romano, A. [1 ]
Sabah, G. [1 ]
Jakobson-Setton, A. [1 ]
Borovich, A. [1 ]
Yeoshoua, E. [1 ]
Eitan, R. [1 ]
机构：
[1] Helen Schneider Hosp Women, Rabin Med Ctr, Gynecol Oncol Div, Petah Tiqwa, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-IGCS.328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
328
引用
收藏
页码：A135 / A136
页数：2
相关论文
共 50 条
  • [41] Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
    Luís Alberto de Pádua Covas Lage
    Débora Toshie Hamasaki
    Frederico Rafael Moreira
    Vanderson Rocha
    Maria Cláudia Nogueira Zerbini
    Juliana Pereira
    Annals of Hematology, 2019, 98 : 2097 - 2102
  • [42] Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
    Aminah Jatoi
    Nathan R. Foster
    Kimberly R. Kalli
    Robert A. Vierkant
    Zhiying Zhang
    Melissa C. Larson
    Brooke Fridley
    Ellen L. Goode
    BMC Cancer, 15
  • [43] Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival
    Mardas, Marcin
    Stelmach-Mardas, Marta
    Madry, Radoslaw
    SUPPORTIVE CARE IN CANCER, 2017, 25 (03) : 795 - 800
  • [44] Effect of chemotherapy delays and dose reductions on progression-free and overall survival in the treatment of epithelial ovarian cancer
    Nagel, C.
    Backes, F.
    Donner, J.
    Hade, E.
    Copeland, L.
    Fowler, J.
    Cohn, D.
    O'Malley, D.
    Eisenhauer, E.
    Salani, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S123 - S123
  • [45] CORRELATION OF PROGRESSION-FREE AND POST-PROGRESSION SURVIVAL WITH OVERALL SURVIVAL IN PHASE III TRIALS OF SECOND-LINE CHEMOTHERAPY ONWARDS FOR ADVANCED OR RECURRENT EPITHELIAL OVARIAN CANCER
    Shimokawa, M.
    Tsukazawa, K.
    Kumagai, H.
    Ohki, M.
    Kaku, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 542 - 542
  • [46] Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
    Jatoi, Aminah
    Foster, Nathan R.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Zhang, Zhiying
    Larson, Melissa C.
    Fridley, Brooke
    Goode, Ellen L.
    BMC CANCER, 2015, 15
  • [47] Estimating changes in overall survival using progression-free survival in metastatic breast and colorectal cancer
    Bowater, Russell J.
    Lilford, Philippa E.
    Lilford, Richard J.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (03) : 207 - 214
  • [48] Progression-Free Survival as a Predictor of Overall Survival in Metastatic Renal Cell Carcinoma Treated With Contemporary Targeted Therapy
    Heng, Daniel Y. C.
    Xie, Wanling
    Bjarnason, Georg A.
    Vaishampayan, Ulka
    Tan, Min-Han
    Knox, Jennifer
    Donskov, Frede
    Wood, Lori
    Kollmannsberger, Christian
    Rini, Brian I.
    Choueiri, Toni K.
    CANCER, 2011, 117 (12) : 2637 - 2642
  • [49] Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
    de Padua Covas Lage, Luis Alberto
    Hamasaki, Debora Toshie
    Moreira, Frederico Rafael
    Rocha, Vanderson
    Nogueira Zerbini, Maria Claudia
    Pereira, Juliana
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2097 - 2102
  • [50] The Waning Relationship Between Progression-Free Survival and Overall Survival in Randomized Cancer Therapy Trials
    Markman, Maurie
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (06) : 30 - 32
12345